Description: Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Home Page: www.iba-worldwide.com
3, Chemin du Cyclotron
Louvain-la-Neuve,
1348
Belgium
Phone:
32 1 047 58 11
Officers
| Name | Title |
|---|---|
| Mr. Pierre Mottet | Chairman of The Board |
| Mr. Olivier Legrain | CEO, Pres, MD & Exec. Director |
| Mr. Yves Jongen | Founder, Chief Research Officer, MD & Exec. Director |
| Ms. Soumya Chandramouli | Chief Financial Officer |
| Mr. Frederic Nolf | Chief HR & Sustainability Officer |
| Olivier Lechien | Corp. Communication Director |
| Mr. Matthias Dierl Ph.D. | Chief Medical Physicist of Radiation Therapy |
| Marc Van der Burght | Exec. VP of Proton Therapy Installation |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 33.67 |
|---|---|
| Trailing PE: | 126.7857 |
| Price-to-Book MRQ: | 4.5326 |
| Price-to-Sales TTM: | 1.423 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1668 |